TMA Highlights Archives - Page 10 of 13 - The Myositis Association

Join us for MyoCon: TMA’s Global Myositis Patient Conference and World Myositis Day! Register Now!

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis

August 23, 2021August 23, 2021

The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of…

TAP INTO THE POWER OF YOUR MIND

August 17, 2021August 17, 2021

With the right intentions, you can use your mind as a tool to achieve amazing things. You know how sometimes one rotten thing can ruin an otherwise wonderful day? What…

TMA New Headquarters

June 1, 2021June 1, 2021

In January 2021, we identified a need to address TMA’s occupancy and our desire to be the best stewards of the organization’s resources. In doing so, we found the Headquarters…

Are you an adult (18 years old or older) diagnosed with dermatomyositis (DM)? Modus Outcomes, a patient-centered outcomes research organization, is conducting 60-minute phone interviews with patients with DM to…

Volunteer opportunities with TMA

February 18, 2021February 18, 2021

We know you have many talents, and we invite you to use them to help us improve the lives of myositis patients everywhere. Whether you have an eye for detail…